UK lab network boosted for public health
In the UK, The Health Protection Agency is planning to revamp the Food, Dairy, Water and Environmental (FDWE) laboratory service network from this November to deal with new outbreaks and emergencies.
Archives for September 30, 2004
Heart attack risk forces Merck to pull $2.5bn Vioxx
A best-selling drug used by millions worldwide to treat arthritis has been withdrawn from the market after comprehensive clinical data confirmed long-established concerns that the treatment could increase the risk of heart attacks and strokes.
Pharmacogenetics shows value in cancer treatment
One of the first trials of pharmacogenetics in a clinical setting has revealed that the approach allowed a cancer drug to be used more effectively in patients with a rare and virulent form of brain cancer,
Invitrogen to supply genomics technology
Invitrogen, a provider of life science technologies, has entered into new licensing agreements to supply its Gateway Technology and clones to worldwide genomic research centres. This will allow scientists and laboratories to share the tools of...
Study backs integrase as novel drug target
A new family of drugs specifically designed to inhibit nuclear import of integrase, blocking viral replication of human immunodeficiency virus type 1 (HIV-1) infected cells suggests an approach that could be effective against drug resistant strains of...
Database deal delivers detailed drug data
Software provider Accelrys becomes the latest company to exploit the use of compound databases in drug discovery. It has agreed to integrate Sigma-Aldrich's chemical compound catalogs into Accelrys' chemical suppliers database enabling researchers to...